Miracle Mile Advisors LLC Sells 1,930 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Miracle Mile Advisors LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 22.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,509 shares of the healthcare conglomerate’s stock after selling 1,930 shares during the period. Miracle Mile Advisors LLC’s holdings in UnitedHealth Group were worth $3,293,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Delta Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares in the last quarter. First PREMIER Bank lifted its stake in UnitedHealth Group by 7.0% during the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock valued at $160,000 after acquiring an additional 18 shares in the last quarter. Genesee Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares during the last quarter. Jmac Enterprises LLC boosted its holdings in UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after purchasing an additional 18 shares during the last quarter. Finally, Matrix Private Capital Group LLC increased its stake in UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 19 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts recently commented on UNH shares. Cantor Fitzgerald increased their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Finally, KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $541.28 on Tuesday. The firm has a market capitalization of $498.13 billion, a PE ratio of 35.26, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The business’s 50-day moving average price is $554.92 and its 200-day moving average price is $562.88. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the firm earned $6.56 EPS. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.